Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
Launched by UNIVERSITY OF ALABAMA, TUSCALOOSA · Apr 7, 2023
Trial Information
Current as of October 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving sleep quality for nursing home residents who have Alzheimer’s disease or related forms of dementia. Researchers are testing a program designed to help these residents sleep better, which is important for their overall health and well-being. The study will also look at how to successfully implement this sleep improvement program in nursing homes and ensure it continues to be used over time.
To participate in the trial, residents must be at least 50 years old and diagnosed with Alzheimer’s disease or similar dementia. They should also be identified by nursing home staff as having sleep problems. However, residents with untreated sleep apnea or certain movement disorders may not be eligible due to challenges in measuring their sleep accurately. Those who join the study can expect to receive support aimed at enhancing their sleep, which could lead to improvements in their daily lives. It's a valuable opportunity to help make a difference in the quality of life for people living with dementia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Nursing home residents aged \>=50 years with an Alzheimer disease or related dementia (ADRD) diagnosis, identified by nursing home staff participating in frontline LOCK sleep huddles as having sleep problems
- Exclusion Criteria:
- • Residents with a high risk of OSA who are not being treated for OSA because actigraph measurements are inaccurate in that population.
- • Residents who have a persistent bilateral resting tremor or paralysis in both arms (a subset of persons with Parkinson's disease and related significant tremor-causing diagnoses), due to actigraph measurement inaccuracies
About University Of Alabama, Tuscaloosa
The University of Alabama, Tuscaloosa, is a leading academic institution dedicated to advancing research and innovation in various fields, including medicine and healthcare. As a clinical trial sponsor, the university leverages its extensive resources, expert faculty, and state-of-the-art facilities to conduct rigorous research that aims to enhance patient care and contribute to medical knowledge. The university fosters collaboration among interdisciplinary teams, ensuring a comprehensive approach to clinical research that prioritizes participant safety and ethical standards. Through its commitment to excellence, the University of Alabama, Tuscaloosa, plays a pivotal role in translating scientific discoveries into effective clinical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lakewood, Colorado, United States
Murfreesboro, Tennessee, United States
San Marcos, Texas, United States
Patients applied
Trial Officials
Lynn Snow, PhD
Principal Investigator
The University of Alabama
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported